Evidence map›Paper›PMID 36793864›Full record

ReviewTheranostics2023

Saliva-based microfluidic point-of-care diagnostic.

Trey W Pittman, Daniel Balazs Decsi, Chamindie Punyadeera, Charles S Henry

Open access · goldAbstract readReview
In one paragraph

Review in Theranostics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Potential of Saliva in Stroke Patients: A Review.International journal of molecular sciences · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. A modular potentiometric sensor platform with detachable microfluidics for multiplexed analysis of low-volume biofluids.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2026
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Saliva-based molecular diagnostics in oral squamous cell carcinoma (OSCC): a non-invasive frontier in oncology.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 4 countries.

Trey W PittmanDepartment of Chemistry, Colorado State University, Fort Collins, Colorado 80523, USA.
Daniel Balazs DecsiCentre for Biomedical Technologies, School of Biomedical Sciences, Faculty of Health, QUT.
Chamindie PunyadeeraGriffith Institute for Drug Discover, Griffith University, Nathan, Australia.
Charles S HenryDepartment of Chemistry, Colorado State University, Fort Collins, Colorado 80523, USA.
Colorado State University · USGriffith University · AUTranslational Research Institute · AU

Funding

Paper-Analytical Device for Saliva Biomarker DiagnosticsR21EB030349 · NIBIB · COLORADO STATE UNIVERSITY · PI HENRY, CHARLES S · 2020 to 2020
$371k
NIBIB NIH HHS R21 EB030349
6 · The paper itself

Abstract

There has been a long-standing interest in point-of-care (POC) diagnostics as a tool to improve patient care because it can provide rapid, actionable results near the patient. Some of the successful examples of POC testing include lateral flow assays, urine dipsticks, and glucometers. Unfortunately, POC analysis is somewhat limited by the ability to manufacture simple devices to selectively measure disease specific biomarkers and the need for invasive biological sampling. Next generation POCs are being developed that make use of microfluidic devices to detect biomarkers in biological fluids in a non-invasive manner, addressing the above-mentioned limitations. Microfluidic devices are desirable because they can provide the ability to perform additional sample processing steps not available in existing commercial diagnostics. As a result, they can provide more sensitive and selective analysis. While most POC methods make use of blood or urine as a sample matrix, there has been a growing push to use saliva as a diagnostic medium. Saliva represents an ideal non-invasive biofluid for detecting biomarkers because it is readily available in large quantities and analyte levels reflect those in blood. However, using saliva in microfluidic devices for POC diagnostics is a relatively new and an emerging field. The overarching aim of this review is to provide an update on recent literature focused on the use of saliva as a biological sample matrix in microfluidic devices. We will first cover the characteristics of saliva as a sample medium and then review microfluidic devices that are developed for the analysis of salivary biomarkers.

Indexed as

MicrofluidicsPoint-of-Care SystemsBiomarkersHumansLab-On-A-Chip DevicesPoint-of-Care TestingSalivaBiomarkersDiagnosticslab-on-chipmicrofluidic.point-of-careSaliva

Identifiers

PMID36793864
PMCPMC9925318
OpenAlexW4318830581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.